The J.P. Morgan Healthcare Conference is one of the largest healthcare investment events in the industry. The event connects industry leaders, emerging fast-growth pharma companies, leading technology innovators and the investment community. ZS once again hosted events aligning to the conference to understand the implications for the biopharma companies we serve.

In this webinar, ZS experts discuss key themes from the conference, including:

• Funding by stage and pipeline focus
• Transactions and partnering
• Rights retention and commercialization